Bo Jesper Hansen

Bo Jesper Hansen

Chairman presso Innoventa Medica ApS

66 anni
Health Technology
Finance
Commercial Services

Profilo

Founder of Scandinavian Medical Research, Bo Jesper Hansen is a Danish businessperson who has been at the head of 13 different companies and presently occupies the position of Chairman for Innoventa Medica ApS and Venture Partner at Wellington Partners GmbH.
Dr. Hansen is also on the board of Reapplix A, MipSalus ApS, Amylon Therapeutics BV and CMC Sweden AB.
In the past Dr. Hansen held the position of Chairman of Karo Healthcare AB, Chairman at Orphazyme A, Chairman of Swedish Orphan Biovitrum AB Chairman of Biovitrum AB, President & Chief Executive Officer for Swedish Orphan International Holding AB and President, Chief Executive Officer & Director at Swedish Orphan Biovitrum International AB (which are all subsidiaries of Swedish Orphan Biovitrum AB), Chairman for Swedish Orphan Biovitrum AB Chairman at Biovitrum AB, President & Chief Executive Officer at Swedish Orphan International Holding AB and President, Chief Executive Officer & Director at Swedish Orphan Biovitrum International AB (which are all subsidiaries of Swedish Orphan Biovitrum AB), Chairman of Karolinska Development AB and Chairman at Karolinska Development AB (Private Equity) (a subsidiary of Karolinska Development AB), Medical Advisor at Yamanouchi Nordic, Medical Advisor at Synthélabo Scandinavia A, Chairman at 2941881 Canada, Inc., Executive Chairman at Topotarget A, Chairman for Ablynx NV, Director-Supervisory Board at Novagali Pharma SA and Medical Advisor at Pfizer ApS.
Dr. Hansen received a doctorate from the University of Copenhagen.

Posizioni attive di Bo Jesper Hansen

SocietàPosizioneInizio
Director/Board Member 15/03/2011
Private Equity Investor -
Innoventa Medica ApS Chairman -
Director/Board Member -
CMC Sweden AB Director/Board Member -
Director/Board Member -
Tutte le posizioni attive di Bo Jesper Hansen

Precedenti posizioni note di Bo Jesper Hansen

SocietàPosizioneFine
SWEDISH ORPHAN BIOVITRUM AB Chairman 05/01/2024
ORPHAZYME A/S Chairman 17/05/2023
Director/Board Member 24/03/2020
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Bo Jesper Hansen

Formazione di Bo Jesper Hansen

University of Copenhagen Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Bo Jesper Hansen

Relazioni

100 +

Relazioni di 1° grado

34

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa8
REBUS HOLDINGS, INC.

Health Technology

KARO PHARMA AB (PUBL)

Health Technology

VALERIO THERAPEUTICS

Health Technology

NEWRON PHARMACEUTICALS S.P.A.

Health Technology

ORPHAZYME A/S

Health Technology

SWEDISH ORPHAN BIOVITRUM AB

Health Technology

KAROLINSKA DEVELOPMENT AB

Finance

ASCELIA PHARMA AB

Health Technology

Aziende private25

Health Technology

Health Technology

Health Technology

Health Technology

Incentive AB

Finance

Health Technology

Finance

Commercial Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Yamanouchi Nordic

Scandinavian Medical Research

Synthélabo Scandinavia A/S

Health Technology

Health Technology

Distribution Services

Distribution Services

Commercial Services

Innoventa Medica ApS

Health Technology

CMC Sweden AB

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Bo Jesper Hansen